Sexual health interventions are effective at increasing both abstinence and condom use in Black adolescents, according to research from North Carolina State University evaluating dozens of studies on interventions and outcomes in…
Cannabis use makes young brains more sensitive to the first exposure to cocaine, according to a new study on rodents led by scientists at Columbia University and the University of Cagliari in…
/Illo_OCD-27724f7986084161a044194d12e99cf2.png "Antibodies Could Provide New Treatment for OCD")
Scientists at Queen Mary University of London and the University of Roehampton, London, have discovered that patients suffering from obsessive compulsive disorder (OCD) have increased levels of a protein called Immuno-moodulin (Imood)…
Gender-based violence has been shown to increase during global emergencies. In a paper just published by Columbia University Mailman School of Public Health, researchers report that according to early evidence it is…
An estimated 25,000 to 28,000 youth transition out of foster care each year in the United States. In a new study, interviews with hundreds of 17-year-olds in the California foster care system…
As droughts become more frequent and intense, the fragmentation of water service in the U.S. among tens of thousands of community systems, most of which are small and rely on local funding,…
Since the beginning of the epidemic until March 25, the mobility restrictions implemented by the Italian government have avoided at least 200,000 hospitalizations and reduced the contagion transmission by 45% according to…
In the urgent battle to treat COVID-19 patients, a group of eleven international medical research organizations is investigating whether overactive immune cells that produce Neutrophil Extracellular Traps (NETs) cause the most severe…
As the coronavirus disease (COVID-19) pandemic advances so does the uncertainty and evolution of the pandemic as it relates to nursing homes and long-term care facilities (LTCF). Early reports suggest the case…
The antiviral drug, baloxavir (tradename Xofluza), is the first treatment for influenza with a new mode of “action” to be licensed in nearly 20 years. It was approved in Australia in February…
